# IGF::OT::IGF Synthetic Peptides and Other Drugs of Abuse; Purity Determination, Stability Testing and Quantitative Analysis. NIDA Ref. No. N01DA-18-8945; POP: 09/29/2018 - 09/28/2019. Base Award

> **NIH NIH N01** · SRI INTERNATIONAL · 2022 · $416,521

## Abstract

Specifically, NIDA through this contract plans to (1) analyze and establish the purity of peptides that are
synthesized through NIDA contracts, (2) regularly monitor the purity and stability of these peptides, and
(3) develop methods and analyze various drugs of abuse and other probes available in the drug supply
inventory for purity and authenticity verification as needed.

## Key facts

- **NIH application ID:** 10703338
- **Project number:** 271201800041C-P00006-9999-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** Jennie Wang
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $416,521
- **Award type:** —
- **Project period:** 2018-09-29 → 2023-09-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703338

## Citation

> US National Institutes of Health, RePORTER application 10703338, IGF::OT::IGF Synthetic Peptides and Other Drugs of Abuse; Purity Determination, Stability Testing and Quantitative Analysis. NIDA Ref. No. N01DA-18-8945; POP: 09/29/2018 - 09/28/2019. Base Award (271201800041C-P00006-9999-1). Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/grant/nih/10703338. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*